064760.KS · 티씨케이
South Korea · RS rating 85 · As of 2026-10-14
| Price | 254,000.00 KRW |
|---|---|
| 1-day change | -7.0% |
| RS rating (overall / 1M / 3M / 12M) | 85 / 56 / 70 / 87 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 36 / 36 / 42 |
| Industry group (rank) | Medical-Generic Drugs (76) |
| EPS growth Q/Q | -5.8% |
| Sales growth Q/Q | -0.5% |
| Distance from 52-week high | +27.1% |
| Market cap (USD) | $2.5B |